2024-09-03 - Analysis Report
## JNJ Stock Analysis Report

This report analyzes the stock of Johnson & Johnson (JNJ), a multinational pharmaceutical, medical devices, and consumer packaged goods company.

**1. Performance Comparison:**

* **JNJ Cumulative Return:** 19.88%
* **S&P 500 (VOO) Cumulative Return:** 89.66%
* **Relative Deviation:** -69.78% (12.84% on relative scale)

JNJ has significantly underperformed the S&P 500 over the considered period.  While the stock has seen some growth, it's fallen behind the broader market by a substantial margin.

**2. Recent Price Movement:**

* **Closing Price:** $165.86
* **5-day Moving Average:** $164.31
* **20-day Moving Average:** $161.22
* **60-day Moving Average:** $154.17

The price has recently been trending upwards, with the closing price exceeding all three moving averages. This suggests potential upward momentum.

**3. Technical Indicators:**

* **RSI:** 74.35
* **PPO:** 0.09
* **Delta_Previous_Relative_Divergence:** -9.44 (indicates a recent short-term downward trend)
* **Expected Return:** 11.93% (estimated 5-year maximum return)

The RSI is nearing overbought territory, suggesting potential for a pullback. The PPO indicates a positive trend. However, the recent relative divergence signal indicates a short-term downward pressure. The expected return is promising, but it's important to note that this is an estimate.

**4. Recent Earnings & Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-25 | 1.95 | 22.45 B$ |
| 2024-05-01 | 1.35 | 21.38 B$ |
| 2024-02-16 | 1.68 | 21.39 B$ |
| 2023-10-27 | 10.32 | 21.35 B$ |
| 2024-02-16 | 10.32 | 21.35 B$ |

The most recent earnings results (2024-07-25) were positive, beating analyst expectations. This reinforces the positive outlook for JNJ.  

**5. Overall Analysis:**

JNJ currently displays mixed signals. While the recent price movement and earnings results are encouraging, the stock's underperformance compared to the broader market and the potential for a near-term pullback are concerns. The strong expected return and positive outlook for the company suggest long-term investment potential.

**6. Conclusion:**

JNJ offers a mixed investment proposition. The company's solid fundamentals and positive earnings are appealing, but its recent underperformance and overbought conditions warrant caution.  Investors should carefully monitor the stock's price action and consider a long-term perspective when making investment decisions.
